Published in Ann Neurol on December 01, 2001
Fluoxetine on Motor Rehabilitation After Ischemic Stroke (FLAME) | NCT00657163
Effect of Serotonin and Levodopa in Ischemic Stroke (SELEIS) | NCT02386475
Cortex Motor Function Reorganization in Stroke Patients | NCT04794673
Mechanisms underlying recovery of motor function after stroke. Arch Neurol (2004) 2.59
Harnessing neuroplasticity for clinical applications. Brain (2011) 2.45
Strategies for stroke rehabilitation. Lancet Neurol (2004) 2.19
A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol (2009) 1.70
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury. J Neurotrauma (2015) 1.42
Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med (2012) 1.34
Pitfalls in FMRI. Eur Radiol (2009) 1.21
Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat (2008) 1.19
Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience (2012) 1.10
Neuroimaging in stroke recovery: a position paper from the First International Workshop on Neuroimaging and Stroke Recovery. Cerebrovasc Dis (2004) 1.07
Neurobiology of rehabilitation. Ann N Y Acad Sci (2004) 1.06
Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. J Neurotrauma (2011) 1.04
Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI. J Vis Exp (2011) 1.01
MR compatible force sensing system for real-time monitoring of wrist moments during fMRI testing. J Neurosci Methods (2006) 0.96
Fluoxetine-induced cortical adult neurogenesis. Neuropsychopharmacology (2013) 0.93
Neuroplasticity and functional recovery in multiple sclerosis. Nat Rev Neurol (2012) 0.93
Altered cerebellar functional connectivity mediates potential adaptive plasticity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2004) 0.92
Depressive syndromes in neurological disorders. Eur Arch Psychiatry Clin Neurosci (2013) 0.91
Management of patients with stroke: is it time to expand treatment options? Ann Neurol (2013) 0.91
Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex. Neuropsychopharmacology (2013) 0.90
Emerging treatments for motor rehabilitation after stroke. Neurohospitalist (2015) 0.87
Escitalopram Decreases Cross-Regional Functional Connectivity within the Default-Mode Network. PLoS One (2013) 0.85
Pharmacologic approaches to cerebral aging and neuroplasticity: insights from the stroke model. Dialogues Clin Neurosci (2013) 0.81
Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav (2015) 0.81
Effects of serotonergic medications on locomotor performance in humans with incomplete spinal cord injury. J Neurotrauma (2014) 0.80
So you think you can jump? A novel long jump assessment to detect deficits in stroked mice. J Neurosci Methods (2015) 0.80
Drugs to Enhance Motor Recovery After Stroke. Stroke (2015) 0.79
Imaging motor recovery after stroke. NeuroRx (2006) 0.79
Paroxetine-induced modulation of cortical activity supporting language representations of action. Psychopharmacology (Berl) (2007) 0.79
Cerebrovascular diseases. Neurol Sci (2008) 0.79
Protective effects of fluoxetine on decompression sickness in mice. PLoS One (2012) 0.78
Divergent modulation of clinical measures of volitional and reflexive motor behaviors following serotonergic medications in human incomplete spinal cord injury. J Neurotrauma (2013) 0.78
Post-stroke depression and the aging brain. J Mol Psychiatry (2013) 0.78
Stroke, dementia, and drug delivery. Br J Clin Pharmacol (2004) 0.77
The "inactivity trap". Gen Hosp Psychiatry (2009) 0.76
Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients? J Neurol (2009) 0.76
Buyang Huanwu Decoction Ameliorates Poststroke Depression via Promoting Neurotrophic Pathway Mediated Neuroprotection and Neurogenesis. Evid Based Complement Alternat Med (2017) 0.75
Acute and chronic effects of noradrenergic enhancement on transcranial direct current stimulation-induced neuroplasticity in humans. J Physiol (2016) 0.75
Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials (2013) 0.75
A novel fMRI paradigm suggests that pedaling-related brain activation is altered after stroke. Front Hum Neurosci (2015) 0.75
Factors affecting post-stroke motor recovery: Implications on neurotherapy after brain injury. Behav Brain Res (2016) 0.75
Genetics as a molecular window into recovery, its treatment, and stress responses after stroke. J Investig Med (2016) 0.75
Imaging stroke recovery: lessons from Prozac. Ann Neurol (2001) 0.75
Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the "spadin" Antidepressant. Front Physiol (2016) 0.75
The anatomy of phonological and semantic processing in normal subjects. Brain (1992) 3.41
Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77
Distribution of cortical neural networks involved in word comprehension and word retrieval. Brain (1991) 2.66
Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol (1992) 2.34
Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology (2010) 2.14
Neuropsychological outcome after a first symptomatic ischaemic stroke with 'good recovery'. Eur J Neurol (2011) 2.13
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain (2000) 2.06
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem (1992) 1.91
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia (2008) 1.67
The delayed-start study in Parkinson disease: can't satisfy everyone. Neurology (2010) 1.63
Wakefulness and loss of awareness: brain and brainstem interaction in the vegetative state. Neurology (2010) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57
Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol (2011) 1.53
A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36. J Med Genet (2002) 1.48
Differential fMRI responses in the left posterior superior temporal gyrus and left supramarginal gyrus to habituation and change detection in syllables and tones. Neuroimage (1999) 1.46
Fou rire prodromique heralding a left internal carotid artery occlusion. Stroke (1997) 1.44
Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology (2001) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Angiographic architecture of intracranial vascular malformations and fistulas--pretherapeutic aspects. Neurosurg Rev (1986) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.36
Within-session and between-session reproducibility of cerebral sensorimotor activation: a test--retest effect evidenced with functional magnetic resonance imaging. J Cereb Blood Flow Metab (2001) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Water drinking and the heart. Lancet (1999) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Sleep attacks and Parkinson's disease treatment. Lancet (2000) 1.25
The accessory middle cerebral artery (AMCA). Diagnostic and therapeutic consequences. Anat Clin (1984) 1.25
Neural substrate for the effects of passive training on sensorimotor cortical representation: a study with functional magnetic resonance imaging in healthy subjects. J Cereb Blood Flow Metab (2000) 1.24
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain (1997) 1.23
True and false fenestration of the vertebral artery. J Neuroradiol (1980) 1.21
Arterial anomalies at the base of the skull. Neuroradiology (1977) 1.16
Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology (2011) 1.15
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology (2011) 1.15
Treatment of Parkinson's disease should begin with a dopamine agonist. Mov Disord (1999) 1.14
Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol (1986) 1.13
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol (1992) 1.13
Mucoceles of the paranasal sinuses: uncommon location. J Laryngol Otol (1998) 1.10
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry (2004) 1.09
Continuous dopamine-receptor stimulation in early Parkinson's disease. Trends Neurosci (2000) 1.07
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology (2002) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Relative value of computed tomography and hypocycloidal tomography in the diagnosis of pituitary microadenoma. A radio-surgical correlative study. Neuroradiology (1981) 1.07
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Posterior extradural migration of extruded thoracic and lumbar disc fragments: role of MRI. Neuroradiology (1999) 1.03
Intracranial dural arteriovenous fistulae with perimedullary venous drainage. Anatomical, clinical and therapeutic considerations. Neuroradiology (1999) 1.03
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. Brain (1998) 1.03
Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet (2000) 1.01
Cavernous hemangiomas of the orbit: MR imaging. J Neuroradiol (1999) 0.99
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging (2001) 0.99
Usefulness of motor functional MRI correlated to cortical mapping in Rolandic low-grade astrocytomas. Acta Neurochir (Wien) (1999) 0.97
Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci (1994) 0.97
[Dilatation of the vein of Galen. Anatomoclinical forms and endovascular treatment apropos of 14 cases explored and/or treated between 1983 and 1986]. Neurochirurgie (1987) 0.97
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry (1994) 0.97
Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol (1999) 0.96
Polymerase chain reaction on cerebrospinal fluid cells in the detection of leptomeningeal involvement by B-cell lymphoma and leukaemia: a novel strategy and its implications. Br J Haematol (1997) 0.95
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Eur J Neurol (2009) 0.95
Diagnosis of C.S.F. rhinorrhoea by computerised cisternography using metrizamide. Lancet (1977) 0.95
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry (2007) 0.94
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol (1999) 0.94
Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage (2005) 0.94
Cerebral thrombophlebitis in three patients with probable multiple sclerosis. Role of lumbar puncture or intravenous corticosteroid treatment. Cerebrovasc Dis (1999) 0.92
Neural correlates of proprioceptive integration in the contralesional hemisphere of very impaired patients shortly after a subcortical stroke: an FMRI study. Neurorehabil Neural Repair (2007) 0.92
Serum lipids in young patients with ischaemic stroke: a case-control study. J Neurol Neurosurg Psychiatry (2000) 0.92
Computed tomography in diabetes insipidus. J Comput Assist Tomogr (1979) 0.92
Pure motor hemiplegia: CT study of 30 cases. Stroke (1982) 0.91
Inflammatory myofibroblastic tumour of the spinal cord: case report and review of the literature. Neuroradiology (2003) 0.91
Cavernous hemangioma of the intracranial optic pathways: CT and MRI. J Comput Assist Tomogr (1999) 0.90
Apomorphine test in parkinsonian syndromes. Lancet (1990) 0.90
Event-related potentials elicited by passive movements in humans: characterization, source analysis, and comparison to fMRI. Neuroimage (1998) 0.90
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease]. Rev Neurol (Paris) (1988) 0.90
[Cerebral hemodynamics and clinical pharmacology in Parkinson disease]. Therapie (1988) 0.90
A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol (1999) 0.90